GLP3-R Research

GLP3-R is a triple agonist peptide that engages the GIP, GLP-1, and glucagon receptors, used in laboratory research to study multi-receptor incretin and energy-expenditure signaling in in-vitro and experimental models.

GLP3-R is a synthetic peptide engineered for balanced activation of three class B GPCRs: the GIP, GLP-1, and glucagon receptors. In reported pharmacology it is markedly more potent at the GIP receptor and comparatively less potent at the glucagon and GLP-1 receptors relative to their native ligands. The added glucagon component is studied for its contribution to energy-expenditure pathways.

Receptor Activity

GLP3-R is studied as a single peptide capable of co-activating three distinct but structurally related receptors. Research characterization reports that it is roughly an order of magnitude more potent at the GIP receptor than native GIP, while acting as a partial-to-moderate agonist at the glucagon and GLP-1 receptors. This tri-agonist balance makes it a unique probe for investigating how simultaneous glucagon, GLP-1, and GIP signaling integrate at the cellular level. Researchers use it to study cAMP output across the three receptor systems, relative agonist potency, and the signaling cross-talk that arises when one ligand recruits multiple GPCR pathways in transfected cells and isolated tissue preparations.

Research Applications

In experimental research models, GLP3-R is investigated for its combined effects on energy intake and energy expenditure, with the glucagon-receptor component studied as a driver of increased metabolic rate alongside GLP-1/GIP-mediated appetite signaling. Experimental studies have examined endpoints including food intake, body composition, gastric emptying, and lipid metabolism. Research hepatic models have also explored triple-agonist activity in steatotic-liver paradigms. GLP3-R commonly serves as a comparator against dual and single incretin agonists to isolate the contribution of glucagon-receptor signaling. All applications are research-use-only investigations in cell systems and experimental models.

Comparative Profile

GLP3-R occupies the most pharmacologically complex position in the incretin tool-compound class: where GLP1-S is a single GLP-1 agonist and GLP2-T a dual GIP/GLP-1 agonist, GLP3-R adds glucagon-receptor activity to create a triple-receptor probe. This makes it especially useful in comparative study designs that aim to dissect the distinct and overlapping roles of all three receptors. As a lyophilized peptide it follows standard laboratory handling: desiccated storage at -20 °C, preparation with sterile or bacteriostatic water, aliquoting to minimize freeze-thaw cycles, and refrigerated working solutions used within a limited window.